RG
KRYS icon

Redmile Group’s Krystal Biotech KRYS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$91.2M Sell
663,471
-74,204
-10% -$10.2M 9.71% 2
2025
Q1
$133M Sell
737,675
-15,500
-2% -$2.79M 12.57% 2
2024
Q4
$118M Sell
753,175
-57,070
-7% -$8.94M 8.22% 2
2024
Q3
$147M Sell
810,245
-210,833
-21% -$38.4M 8.69% 1
2024
Q2
$188M Sell
1,021,078
-487,172
-32% -$89.5M 11.34% 1
2024
Q1
$268M Sell
1,508,250
-224,939
-13% -$40M 9.85% 1
2023
Q4
$215M Sell
1,733,189
-270,178
-13% -$33.5M 7.69% 2
2023
Q3
$232M Sell
2,003,367
-563,294
-22% -$65.3M 11.06% 2
2023
Q2
$301M Buy
2,566,661
+653,381
+34% +$76.7M 11.57% 2
2023
Q1
$153M Buy
1,913,280
+16,635
+0.9% +$1.33M 6.65% 2
2022
Q4
$150M Sell
1,896,645
-2,900
-0.2% -$230K 6.15% 2
2022
Q3
$132M Buy
1,899,545
+1,000
+0.1% +$69.7K 5.14% 3
2022
Q2
$125M Buy
1,898,545
+82,847
+5% +$5.44M 4.76% 5
2022
Q1
$121M Sell
1,815,698
-5,200
-0.3% -$346K 3.77% 5
2021
Q4
$127M Sell
1,820,898
-161,534
-8% -$11.3M 2.9% 9
2021
Q3
$104M Sell
1,982,432
-89,700
-4% -$4.68M 1.81% 19
2021
Q2
$141M Buy
2,072,132
+12,000
+0.6% +$816K 2.09% 14
2021
Q1
$159M Buy
2,060,132
+385,096
+23% +$29.7M 2.24% 13
2020
Q4
$101M Buy
1,675,036
+173,091
+12% +$10.4M 1.22% 23
2020
Q3
$64.7M Buy
1,501,945
+92,200
+7% +$3.97M 1.19% 29
2020
Q2
$58.4M Buy
1,409,745
+357,945
+34% +$14.8M 1.08% 29
2020
Q1
$45.5M Sell
1,051,800
-38,400
-4% -$1.66M 1.28% 28
2019
Q4
$60.4M Buy
1,090,200
+11,900
+1% +$659K 1.44% 23
2019
Q3
$37.4M Sell
1,078,300
-2,000
-0.2% -$69.5K 1.25% 25
2019
Q2
$43.5M Buy
1,080,300
+755,800
+233% +$30.4M 1.23% 26
2019
Q1
$10.7M Sell
324,500
-500
-0.2% -$16.5K 0.31% 53
2018
Q4
$6.75M Buy
+325,000
New +$6.75M 0.27% 57